Jim Simons Codex Dna, Inc. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
N/A
27,547 New
27,547 $11,000
Q2 2023

Aug 11, 2023
SELL
N/A
-3,094 Reduced 3.24%
92,300 $146,000
Q1 2023

May 12, 2023
BUY
$1.3 - $2.15 $18,582 - $30,732
14,294 Added 17.63%
95,394 $296,000
Q4 2022

Feb 13, 2023
SELL
$1.12 - $1.69 $71,792 - $108,329
-64,100 Reduced 44.15%
81,100 $97,000
Q3 2022

Nov 14, 2022
BUY
$1.7 - $2.36 $246,840 - $342,672
145,200 New
145,200 $241,000

Others Institutions Holding DNAY

# of Institutions
1
Shares Held
307
Call Options Held
0
Put Options Held
0
View Full List

About Codex DNA, Inc.

DNAY Quotes by TradingView
  • Ticker DNAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,518,200
  • Market Cap $54.6M
  • Description
  • Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...
More about DNAY
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email